Showing results (211-220 of 775) with videos related to

Sort By:
Pageof 78
The Journal of Invasive Cardiology|January 6, 2023
Efficacy and Safety of an Upfront RotaTripsy Strategy in the Treatment of De Novo and In-Stent Restenosis CasesPrashant Dwivedi, Vishal Dhulipala, Kartik R Kumar, et al.
JACC. Advances|June 23, 2026
SGLT-2 Inhibitors and Outcomes After Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-AnalysisOmer Mohammed, Kaandeeban Mohanraj, Diya Chakraborty, et al.
Journal of Clinical Medicine|August 12, 2022
Evolving Devices and Material in Transcatheter Aortic Valve Replacement: What to Use and for WhomMauro Chiarito, Alessandro Spirito, Johny Nicolas, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 20, 2013
Impact of antithrombotic treatment on short-term outcomes after percutaneous coronary intervention for left main disease: a pooled analysis from REPLACE-2, ACUITY, and HORIZONS-AMI trialsTobias Geisler, Karin Müller, Athanasios Karathanos, et al.
International Journal of Cardiology|February 15, 2024
Impact of diabetes mellitus on clinical outcomes after first episode in-stent restenosis PCI: Results from a large registryRichard Tanner, Serdar Farhan, Gennaro Giustino, et al.
Journal of Thrombosis and Thrombolysis|December 1, 2007
Comparison of the effects of pretreatment with tirofiban, clopidogrel or both on the inhibition of platelet aggregation and activation in patients with acute coronary syndromesEmilia Solinas, Giuliana Gobbi, George Dangas, et al.
The Annals of Thoracic Surgery|December 26, 2024
Causes of Death After Coronary Revascularization in Patients With DiabetesLucas C Godoy, Valentin Fuster, Louai Razzouk, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 11, 2023
Coronary Stent Infections - A Systematic Review and Meta-AnalysisVenkatakrishnan Ramakumar, Abhishek Thakur, Rizwan Suliankatchi Abdulkader, et al.
The American Journal of Cardiology|September 22, 2010
Comparison of Bivalirudin versus Bivalirudin plus glycoprotein IIb/IIIa inhibitor versus heparin plus glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes having percutaneous intervention for narrowed saphenous vein aorto-coronary grafts (the ACUITY trial investigators)Dinesh Kumar, George Dangas, Roxana Mehran, et al.
Epidemiology (Cambridge, Mass.)|June 20, 2002
New-device angioplasty in women: clinical outcome and predictors in a 7,372-patient registryAlexandra J Lansky, Roxana Mehran, George Dangas, et al.
Pageof 78